Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects Intravenous Iron and Oral Iron Therapy on Erythropoietin Dose in Maintenance Hemodialysis Patients: An Open-label, Randomized, Controlled Study

NCT04464850 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

NCT NCT04464850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects Intravenous Iron and Oral Iron Therapy on Erythropoietin Dose in Maintenance Hemodialysis Patients: An Open-label, Randomized, Controlled Study
Lead sponsor
Chiang Mai University
Phase
Phase 3
Overall status
Unknown status
Start date
July 29, 2020
Completion date
July 31, 2022
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hemodialysis complication, iron deficiency anemia